DCRI, Verily, and HERO Registry to Support Long-Term Safety Study of COVID-19 Vaccine,

Following a global Phase 3 clinical trial involving more than 44,000 participants across 155 sites, the U.S. Food and Drug Administration granted an …, Following a global Phase 3 clinical trial involving more than 44,000 participants across 155 sites, the U.S. Food and Drug Administration granted an …, Read More

Scroll to Top